Bryostatin Treatment of Moderately Severe Alzheimer's Disease
Clinical trial NCT04538066 · COMPLETED
Trial details
- NCT number
- NCT04538066
- Sponsor
- Neurotrope Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-30
- Primary completion
- 2022-11-16
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.